Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 5/20 | 0.42 |
| ▸ | CTSG | P08311 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | BRD1 | O95696 | 2/20 | 0.39 |
| ▸ | TAF1 | P21675 | 2/20 | 0.39 |
| ▸ | BRPF1 | P55201 | 2/20 | 0.39 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.39 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.39 |
| ▸ | KCNH2 | Q12809 | 6/20 | 0.37 |
| ▸ | TAF1L | Q8IZX4 | 1/20 | 0.37 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.37 |
| ▸ | CECR2 | Q9BXF3 | 1/20 | 0.37 |
| ▸ | BRPF3 | Q9ULD4 | 1/20 | 0.37 |
| ▸ | BID | P55957 | 3/20 | 0.37 |
| ▸ | MCL1 | Q07820 | 3/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23592281 | 1.00 | ELANE (0.42) | ELANECTSGMEN1POLBMAPT | |
| SCHEMBL17231433 | 1.00 | ELANE (0.42) | ELANECTSGMEN1POLBMAPT | |
| SCHEMBL17146973 | 1.00 | ELANE (0.42) | ELANECTSGMEN1POLBMAPT | |
| SCHEMBL23592283 | 1.00 | ELANE (0.42) | ELANECTSGMEN1POLBMAPT | |
| SCHEMBL17231431 | 1.00 | ELANE (0.42) | ELANECTSGMEN1POLBMAPT | |
| SCHEMBL23592284 | 0.99 | MEN1 (0.41) | ELANECTSGMEN1POLBMAPT | |
| SCHEMBL17231423 | 0.96 | KMT2A (0.42) | ELANECTSGMEN1POLBMAPT | |
| SCHEMBL17146962 | 0.88 | MAPT (0.46) | MEN1POLBMAPTKMT2AL3MBTL1 | |
| SCHEMBL17146964 | 0.87 | ELANE (0.44) | ELANECTSGMEN1POLBMAPT | |
| SCHEMBL21389598 | 0.86 | TDP1 (0.41) | MEN1POLBMAPTKMT2AL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11754920-B2 | Thermal acid generator and resist composition using same | ADEKA CORPORATION (JP) | 2023-09-12 | — | — | US | disclosed |
| US-11754920-B2 | Thermal acid generator and resist composition using same | ADEKA CORPORATION (JP) | 2023-09-12 | — | — | US | disclosed |
| US-20220197136-A1 | THERMAL ACID GENERATOR AND RESIST COMPOSITION USING SAME | ADEKA CORPORATION (JP) | 2022-06-23 | — | — | US | disclosed |
| US-20200183271-A1 | THERMAL ACID GENERATOR AND RESIST COMPOSITION USING SAME | ADEKA CORPORATION (JP) | 2020-06-11 | — | — | US | disclosed |
| US-20190294044-A1 | POSITIVE PHOTOSENSITIVE COMPOSITION, PATTERN USING SAME, AND METHOD OF MANUFACTURING PATTERN | ADEKA CORPORATION (JP) | 2019-09-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200183271-A1 | THERMAL ACID GENERATOR AND RESIST COMPOSITION USING SAME | ACSL1, GAR1, LRBA | ELANE 4578/4885CTSG 3249/4885MEN1 753/4885 |
| US-11754920-B2 | Thermal acid generator and resist composition using same | ACSL1, LRBA, GAR1 | ELANE 4549/4885CTSG 2889/4885MEN1 631/4885 |
| US-20220197136-A1 | THERMAL ACID GENERATOR AND RESIST COMPOSITION USING SAME | ACSL1, LRBA, GAR1 | ELANE 4549/4885CTSG 2889/4885MEN1 631/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.